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Ames, Iowa 50011, United States
§Ames National Laboratory, Ames, Iowa 50011, United States
ABSTRACT: Of central importance to tissue engineering and
drug delivery is identifying polymer parameters that increase
or decrease speciﬁc cytokines in response to biomaterials. In
this study, we have interrogated the eﬀects of material
descriptors and material characteristics on pro-inﬂammatory,
pro-angiogenic, and naiv̈e macrophages using polymeric
particles (∼600 nm), functionalized with 13 diﬀerent moieties.
We characterized tumor necrosis factor-α (TNF-α) and
interleukin-10 (IL-10) secretion for the three macrophage
populations and used the quantitative structure−activity
relationship method (QSAR) to accurately predict cytokine secretion for the diﬀerent macrophage phenotypes. The ﬁndings
presented here demonstrate that altering cellular responses to polymers can be achieved through exploiting material parameters.
For pro-inﬂammatory macrophages, polarity and the ability to hydrogen bond appear to signiﬁcantly impact TNF-α secretion
while charge impacted pro-angiogenic macrophages. Naiv̈e cells were impacted by charge in a similar manner as the pro-
angiogenic cells; however, hydrophilicity also increased TNF-α secretion in these cells. For IL-10 secretion, hydrogen bonding
was very negatively correlated with pro-inﬂammatory cells, whereas it was positively correlated with pro-angiogenic cells.
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1. INTRODUCTION
Surfaces play an integral role on cellular responses.1−4 The
properties that these surfaces possess, such as hydrophobicity5,6
and stiﬀness,7−9 can inﬂuence the cell, in particular the
cytokines secreted.10−12 Altering the chemical properties of
the polymers that interact with cells can modulate their
activity.13 In particular, these surfaces can alter macrophage
phenotype. Macrophages exist on a continuum of phenotypes
with the extremes being pro-inﬂammatory, known as M1
macrophages, and pro-angiogenic, referred to as M2. The
classically activated M1 phenotype arises in response to
interferon-γ (IFN-γ) or lipopolysaccharide (LPS).14 The pro-
angiogenic alternatively activated M2 macrophages are
generated upon exposure to interleukine-4 (IL-4).15,16 Alter-
natively activated macrophages have been shown to reduce
histological and functional injury as opposed to classically
activated macrophages,17 and thus, developing an under-
standing of the material properties that promote M2 macro-
phages would be a useful tool in tissue engineering and for the
ﬁeld of biomaterials.
A large amount of these pro-inﬂammatory mediators are
secreted by macrophages and help tumor cells proliferate and
survive. A consequence of this was that normal cytokine
secretion was suppressed. These early tumor cells were called
M1-like macrophages, which are transformed to M2-like
macrophages.18 These cells, also called tumor-associated
macrophages (TAMs), produce a large amount of IL-10,
express a low level of pro-inﬂammatory cytokines, and possess
poor antigen presenting capabilities. Speciﬁcally, TAMs
produce anti-inﬂammatory cytokines such as IL-10 and
angiogenic factors such as transforming growth factor,
epidermal growth factor, and vascular endothelial growth
factor. They also secrete a decreased level of reactive nitrogen
intermediates and have decreased antigen presentation and
tumoricidal capacity, as measured by a decrease in tumor
necrosis factor-α (TNF-α). The expression proﬁle of TAMs
drives cellular proliferation and angiogenesis.19−21 Reprogram-
ming tumor-promoting macrophages is a potential therapeutic
strategy that has been addressed through administration of IL-
12.22 IL-12 enhances antigen presentation in macrophages and
can induce IFN-γ, which promotes an M1 phenotype.23 The
potential for polymers to alter cytokine secretion has been
demonstrated,13 illustrating the need to develop predictive
models for these cellular responses.
Here, we present a potential platform for engineering
macrophage responses to elicit changes in cytokine secretion
for possible use as a drug delivery vehicle for chemo-
therapeutics that reprograms TAMs to act synergistically with
the drug regimen. In particular, this study focuses on increasing
the level of TNF-α and decreasing the level of IL-10 expressed
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by macrophages. TNF-α is toxic to tumor cells at suﬃcient
levels24 and tumor promoting at others.25 Furthermore, the
maximum tolerated dose for systemic delivery of TNF-α in
humans is 200−400 mg/m2,26,27 which is too low to induce a
response in tumors. IL-10 is a pleiotropic cytokine that can
activate and induce proliferation of B-lymphocytes and confer
survival to certain tumors.28,29 The preceding citations and
related discussion illustrate the importance of altering macro-
phage cytokine production proﬁles at the tumor site to cause
tumor regression. In this paper we demonstrate the ability to
alter TNF-α and IL-10 through modifying surface properties of
a model polymeric particle for potential applications in
immunomodulative drug delivery. The library of materials
examined were based on p(N-isopropylacrylamide-co-acrylic
acid) (p(NIPAm-co-AAc)), which has good biocompatibility
and has attracted attention from both academic and industrial
researchers.30−33 The macrophages were treated with LPS or
IL-4 to induce M1 or M2 phenotypes. Naiv̈e cells were also
tested. Correlations between the cytokines secreted and the
material properties were examined and a predictive mathemat-
ical model for the two cytokines and three macrophage
treatments was developed.
2. MATERIALS AND METHODS
Thirteen chemically unique functional groups were coupled to
polymers to assess how they aﬀect macrophage activation. All
experiments had at least four replicates and error bars indicated the
standard deviation. All materials were purchased from Sigma (St.
Louis, MO) and used as received, unless otherwise indicated. Fresh
deionized water (Milli-Q, Barnstead Nanopure, Thermo Scientiﬁc,
Waltham, MA) was used throughout this study.
Monomers that were coupled to p(NIPAm-co-AAc) particles were:
3-butenylamine (Santa Cruz Biotechnology, Dallas, TX);1,4-dioxan-2-
ylmethanamine; glycidamide; 4-amino-3-penten-2-one; malonamide
(Fisher, Pittsburgh, PA); tert-butyl 4-aminobutanoate (VWR, Radnor,
PA); aminoacetaldehyde dimethyl acetal (Alfa Aesar, Ward Hill, MA);
3-aminobenzamide oxime; 2,4-dinitro-phenyl-hydroxylamine; 1-
Amino-4-oxocyclohexanecarboxylic acid ethylene ketal; 2-amino-
ethylmethylsulfone hydrochloride; 3-amino-1-propanesulfonic acid
(Fisher, Pittsburgh, PA); and aminomethylphosphonic acid (Alfa
Aesar, Ward Hill, MA).
2.1. Polymer Synthesis. 2.1.1. p(NIPAm-co-AAc) Particle Syn-
thesis. The synthesis and modiﬁcation of p(NIPAm-co-AAc) particles
has been described previously.34 Brieﬂy, NIPAm (2.4 g), N,N-
methylenebis(acrylamide) (0.16 g), and 157 μL of AAc (J.T. Baker,
Center Valley, PA) were dissolved in 100 mL of H2O and stirred
under N2 in a 250 mL round-bottom ﬂask for 30 min at 70 °C. Then,
200 mg of K2S2O8 was dissolved in 10 mL of H2O and added to the
ﬂask. After 4 h, the suspension was slowly cooled to room
temperature, ﬁltered with P5 grade ﬁlter paper, and dialyzed for 48
h in Milli-Q water. The particles were freeze-dried using a lyophilizer
(Labconco, Kansas City, MO, 4.5L).
In a 15 mL tube, 3 mL of phosphate buﬀered saline (PBS, diluted
from 10X solution, Fisher Scientiﬁc to 0.1M, pH 7.4), 6 mg of
monomers, 0.6 mL of 5% w/v p(NIPAm-co-AAc) particles, and 60 mg
of 1-ethyl-3(−3-(dimethylamino)propyl) carbodiimide hydrochloride
were vortexed and incubated overnight at room temperature. The
particles were dialyzed for 24 h in H2O and lyophilized. The particles
were reconstituted at 1% w/v in H2O. To ensure that the
modiﬁcations proceeded to the same % reaction, NMR was used to
characterize the modiﬁed particles. The modiﬁed particles were
suspended in D2O. The
1H spectra were recorded on a Bruker Avance
III Spectrometer with a sweep width of 6602.1 Hz, a 90° pulse, and an
acquisition time of 2.48 s. Sixteen repetitive scans with 64k points were
acquired and the data were processed in MNova with 128k points,
zero ﬁlling, and exponential line broadening of 1.0 Hz. NMR was able
to determine that the 54 ± 2% of carboxylic group on AAc were
modiﬁed for all of the functionalizations.
2.2. Cell Viability. RAW 264.7 macrophages were cultured at 37
°C with 5% CO2 in 10% fetal bovine serum, 100 U/L penicillin, and
100 μg/L streptomycin in Dulbecco’s modiﬁed Eagle’s medium
(DMEM High Glucose; Thermo Scientiﬁc), to be referred to as
complete media (CM). RAW 264.7 cells were seeded in a 24-well plate
at 1.25 × 105 cell/cm2 in the presence of 5 μg/mL LPS or 25 ng/mL
IL-4 (eBioscience Inc., San Diego, CA) and incubated 24 h at 37 °C in
5% CO2. A control set of experiments was not activated. After
activation, particles were added to the wells (100 particles per cell) and
incubated for 24 h. All particles were sterilized by washing three times
in 70% ethanol, followed by three washed in sterile H2O by
centrifuging at 10 000 g for 3 min. In a control experiment, cells
were incubated without particles. A control of particle and IL-4 or LPS
in the absence of cells was also conducted. The media in each well was
collected and stored at −20 °C.
Cell viability was determined through an MTT (3-(4,5-dimethylth-
iazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. After the super-
natants were removed, 50 μL of a MTT solution (5 mg/mL in DI
water) and 500 μL of CM were added to the wells and incubated for 2
h at 37 °C in 5% CO2. Then 425 μL of media was aspirated. The
crystalline deposits were dissolved using 500 μL of dimethyl sulfoxide
(DMSO, Fisher, Pittsburgh, PA). The optical density (OD) at 540 nm
was measured using a plate reader (BioTek Synergy HT Multi-
detection Microplate Reader, Winooski, VT) with a reference at 690
nm.
2.3. Measurement of Cytokine Production. The supernatants
removed in the above section were analyzed for cytokine production.
Secretion of tumor necrosis factor-α (TNF-α) and IL-10 in LPS, IL-4,
or naiv̈e cell supernatant were determined by commercially available
immunoassay kits (eBioscience Inc., San Diego, CA) and performed as
described by the manufacturer.
2.4. Statistics and Data Analysis. Statistical analysis was
performed using XLSTAT statistical software (New York, NY).
Statistical signiﬁcance of the mean comparisons was determined by
ANOVA. Diﬀerences were considered statistically signiﬁcant for p <
0.05. The data generated for IL-10 and TNF-α secretion in LPS, IL-4,
and naiv̈e cells were split into two sets: training and validation sets,
making sure that the values in the validation set were distributed
throughout the range of secretions. The training set was used to
develop the QSAR model through partial least-squares regression. The
materials descriptors (Table 1) were developed based on descriptors
deﬁned by Bicerano.35 The validation set was used to verify the QSAR
model. The validation sets for TNF-α were: alkene, ether, ketone,
amide, and phosphonic acid for LPS stimulated cells; epoxide, ester,
ketone, nitro, sulfone, and unmodiﬁed for IL-4 stimulate macrophages;
and acetal, alkene, ether, sulfonic acid, and unmodiﬁed for naiv̈e cells.
The validation sets for IL-10 were: acetal, amide, epoxide, ketal, and
sulfonic acid for LPS stimulated cells and acetal, amide, ether, nitro,
and phosphonic acid for IL-4 stimulate cells. Because the secreted
protein was not well correlated between stimulations or surface
modiﬁcations, the validation sets were chosen independently for each
cytokine and activation.
3. RESULTS
3.1. Cell Viability. Functionalized p(NIPAm-co-AAc)
particles were synthesized, functionalized, and characterized
for their ζ-potential, water contact angle (WCA), melting
temperature, and ability to activate complement through the
alternative pathway as previously described.34 The chemical
structures of the molecules attached to the particles are shown
in Figure 1. These results have been reprinted with
permission34 in Figure 2. The particles size was conﬁrmed
through scanning electron microscopy and the % functionaliza-
tion of the particles was analyzed through NMR. Cell
compatibility studies of these materials were performed by
treating RAW 264.7 macrophages with LPS or IL-4 for 24 h,
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followed by addition of functionalized p(NIPAm-co-AAc)
particles and assayed for metabolic activity 24 h later. Naiv̈e
macrophages were also tested. The results for the cytotoxicity
experiments have been previously reported.34 The p(NIPAm-
co-AAc) particles showed minimal toxicity for all treatments
and for all particles. RAW 264.7 cells are a common model for
studying macrophage function and activation.36,37
3.2. TNF-α and IL-10 Secretion from Activated and
Naiv̈e Macrophages. TNF-α production by activated and
naiv̈e macrophages in response to 24h incubation with
functionalized p(NIPAm-co-AAc) particles is shown in Figure
3A. Functionalizations acetal, alkene, ester, ether, ketal, ketone,
nitro, oxime, phosphonic acid, and sulfonic acid all decreased
TNF-α expression compared to the unmodiﬁed p(NIPAm-co-
AAc) particles (p < 0.05) for LPS stimulated macrophages. The
largest decrease was ∼40% for the oxime functionalized
particle. A control of LPS stimulated macrophages without
particles was also run and yielded 4.89 ± 0.59 ng TNF-α
/250 000 cells, which was statistically higher than cells treated
with alkene, ketal, ketone, nitro, or oxime functionalized
particles (p < 0.05). For IL-4-treated macrophages, ester, ether,
ketal, and sulfonic acid functionalized particles resulted in
statistically larger TNF-α expression compared to the
unmodiﬁed particles (p < 0.05), whereas amide, nitro, and
oxime decreased TNF-α. Cells treated with IL-4 and no
particles resulted in 1.55 ± 0.22 ng TNF-α/250 000 cells. In
comparing to cells treated with IL-4 without particles, ether,
ketal, and sulfonic acid functionalized particles increased TNF-
α secretion (p < 0.05). The naiv̈e macrophages without
particles yielded 0.55 ± 0.02 ng TNF-α /250 000 cells. With
the exception of the unmodiﬁed p(NIPAm-co-AAc) and oxime,
phosphonic acid, and sulfone modiﬁed particles, the addition of
particles resulted in a signiﬁcant increase in TNF-α. Sulfonic
acid and ketal functionalized particles resulted in a 15-fold
increase over unmodiﬁed particles. Acetal, epoxide, ester, ether,
and nitro functionalized particles increased TNF-α expression
7-fold, and alkene, amide, and ketone increased secretion 3-
fold.
IL-10 secretion for LPS and IL-4 stimulated macrophages is
shown in Figure 3B. IL-10 secretion for naiv̈e cells is also given
in Figure 3B as 10× the secreted ng IL-10/250 000 cells. LPS
resulted in no signiﬁcant diﬀerences between the unmodiﬁed
p(NIPAm-co-AAc) particles and the control without particles,
which secreted 4.33 ± 0.72 ng IL-10/250 000 cells. Statistically
Table 1. Twenty-Two Molecular Descriptors for the Surface
Modiﬁcations Used in This Studya
ID
structure
descriptor descriptions
1 R freely rotating bonds
2 HD H-bond donors
3 HA H-bond acceptors
4 Nsp2 number of sp
2 carbon atoms
5 N1 °C number of 1° carbon atoms
6 1X connectivity index 1
7 1Xv connectivity index 2
8 0X atomic index 1
9 0Xv atomic index 2
10 N number of non-hydrogen atoms
11 NC number of carbon atoms
12 NH number of hydrogen atoms
13 NO number of oxygen atoms
14 NN number of nitrogen atoms
15 NCH2 number of CH2
16 NK NK = 5Namide + 4Nhydroxyl − 3Nether − 5NCC + 3Nsulfone
17 Ndc Ndc = 19NN + 12N(side group O,‑S‑) + 52Nsulfone − 14Ncyc
18 Ngroup Ngroup = 12Nhydroxyl + 12Namide + 2N(nonamide‑(NH)‑unit) −
N(alkyl ether‑O−) − NCC + 4N(nonamide‑(CO)‑next to a nitrogen) +
7N(−(CO)‑incarboxylic acid, ketone, or aldehyde) + 2N(other−(CO)−)
19 M molecular weight
20 Tam melting temperature
21 ζ zeta potential
22 WCA water contact angle
aThe structure descriptors are deﬁned by Bicerano.34.
Figure 1. Chemical structures of all molecules used for the modiﬁcation of p(NIPAm-co-AAc) particles through the amine group. Their functional
groups were used as labels in following ﬁgures for convenience.
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signiﬁcant decreases in IL-10 were observed for ether, oxime,
phosphonic acid, and sulfonic acid functionalized particles (p <
0.05). A greater variation in expression levels was observed for
cells stimulated with IL-4 in the presence of particles. All of the
modiﬁed polymers except oxime were statistically higher than
the unmodiﬁed particle, with ketal being 5-fold and sulfonic
acid being 3-fold higher than the unmodiﬁed particle. The IL-4
stimulated control without particles secreted 2.31 ± 0.06 ng IL-
10/250 000 cells. The naiv̈e cells secreted very low levels of IL-
10 with the control without particles yielding 0.16 ± 0.01 ng
IL-10/250 000 cells. The expression levels shown in Figure 3B
for the naiv̈e cells are 10× higher than the measured values.
The limit of detection and limit of quantiﬁcation were found to
be 0.03 and 0.07 ng IL-10/250 000 cells, indicating that all
samples had detectable IL-10, but not all were quantiﬁable. For
this reason, statistical diﬀerences between naiv̈e macrophages
treated with particles were not considered.
4. DISCUSSION
4.1. Material Parameters That Inﬂuence TNF-α
Secretion in Activated and Naiv̈e Macrophages.
Secretion of TNF-α in the absence of particles was highest
for LPS-treated, followed by IL-4-treated, and naiv̈e cells, which
is expected.13,36,38 Upon addition of particles, LPS-treated
particles secrete more TNF-α than their IL-4-treated counter-
parts. The naiv̈e cells, however, express signiﬁcantly more TNF-
α than their LPS-treated counterparts for ester, ether, ketal,
nitro, and sulfonic acid functionalized particles (p < 0.05). One
of the factors that can cause the naiv̈e macrophages to produce
more TNF-α than the LPS stimulated cells is that IL-10 is a
suppressor of TNF.39 Nathan and co-workers have reported
that 0.1 ng/mL IL-10 could suppress TNF-α secretion from
LPS stimulated cells by a factor 21.4 ± 2.5.40 An additional
explanation is that macrophages can develop an LPS tolerance
in which synthesis of TNF-α is diminished.41
The focus of this work was to examine how material
properties inﬂuence cytokine expression from activated and
naiv̈e macrophages. Partial least-squares analysis was performed
on the TNF-α secretion from LPS, Il-4, and naiv̈e macrophages
and the material properties of the particles incubated with those
macrophages are shown in Figure 4. QSAR was used to build
equations connecting the material descriptors in Table 1 to the
TNF-α expression. The data set was split into a training set,
which was used to build the mathematical model, and a
validation set, which measured the predictive ability of the
model. The model was able to develop equations for TNF-α
expression that were dependent on six or fewer material
parameters. The models are shown below.
α− = + − −
− −
N H
N
TNF 5.387 0.063 0.067 X 0.163
0.016H 0.060
LPS K
0 v
D
A sp2 (1a)
α ζ− = − + −
+ −
− NTNF 1.502 0.019 0.142 0.063 X
0.225 X 0.153H
IL 4 CH2
1
1 v
A (1b)
α ζ− = − −
+ + +
−
̈
N N N
TNF 17.196 0.155 0.392WCA
0.140 1.473 0.505
0.832H
naive
group CH2 O
D (1c)
The results for the goodness of the ﬁts on the training set for
the above equations are as follows: (1a) the predicted Y-
variation, Q2Y = 0.931 and the explained Y-variation, R2Y =
0.980; (1b) Q2Y = 0.974, R2Y = 0.995; and (1c) Q2Y = 0.843
and R2Y = 0.975 (Figure 4). For a good ﬁt, the diﬀerence
between R2Y and Q2Y should be less than 0.2,42,43 with a
Figure 2. Material characterization of modiﬁed p(NIPAm-co-AAc)
particles. (A) Zeta potential, (B) water contact angle, (C) melting
temperature, and (D) percentage of red blood cell lysis from
alternative activation of complement. Zeta potential and percentage
of lysis data represents three replicates for each sample. Water contact
angle represents ﬁve replicates for each sample. All data are shown by
mean value ± standard deviation. Reproduced with permission.34
Copyright 2014 American Chemical Society.
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diﬀerence greater than 0.2 indicating the presence of outliers.
Eriksson has stated that Q2Y > 0.5 is generally regarded as good
and Q2Y > 0.9 is excellent.42 For in vitro experiments, R2 should
be ≥0.81 for a good ﬁt.44 Our models were able to satisfy these
requirements.
For M1 macrophages there was a positive correlation (R =
0.818) with NK and a negative correlation with Nsp2 (R =
−0.719). NK is used as a correction factor for the prediction of
viscosity and includes polar functional groups, along with C
C. In addition, hydrogen bond donors and acceptors have
negative correlations with TNF-α expression (R = −0.836 and
−0.532, respectively). The atomic index 2, which is a measure
of the hybridization and number of hydrogen atoms attached to
each atom in the modiﬁcation listed in Figure 1, with fewer
hydrogen atoms and increased hybridization leading to a larger
number. It is important to note that the number of hydrogen
atoms attached to non-hydrogen atoms in the modiﬁcation is
generally more impactful than the hybridization on the atomic
index. The correlation between TNF-α expression and the
atomic index 2 is R = −0.698. The overarching theme of these
parameters appears to be that the polarity and ability to H-bond
alters the TNF-α expression for M1 polarized cells.
For M2 polarized cells, there are positive correlations with
the number of CH2 groups; and the ﬁrst and second
connectivity indices (R = 0.819, 0.574, 0.733, respectively)
and a negative correlation with the ζ-potential and hydrogen
bond acceptors (R = −0.843 and −0.248). Taken together,
these factors indicate that the charge of the particle is inﬂuential
on the TNF-α expression for M2 polarized cells.
Naiv̈e cells were exposed to modiﬁed particles and their
TNF-α secretion was modeled through QSAR, which is shown
in eq 1c. Six parameters were used to build the model including
ζ-potential (R = −0.714), WCA (R = −0.320), Ngroup (R =
−0.182), the number of CH2 groups (R = 0.660), the number
Figure 3. Cytokine expression (A) TNF-α and (B) IL-10 secretion by macrophages in response to functionalized p(NIPAm-co-AAc) particles and
stimulation with LPS or IL-4. Naiv̈e cells are also shown. Positive controls (PC) without particles are shown for both activations, as well as for naiv̈e
cells. * p < 0.05 compared with pNIPAm.
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of oxygen atoms (R = 0.634), and the number of hydrogen
bond donors (R = −0.407). These parameters suggest that
hydrophilic, negatively charged particles will increase the
amount of TNF-α secreted from the cells. In examining Figure
3A ketal and sulfonic acid functionalized particles secrete
substantially more TNF-α compared to the other functionalized
particles incubated with naiv̈e cells and with all of the LPS and
IL-4 stimulated macrophages. In examining material properties
such as ζ-potential and WCA, neither ketal nor sulfonic acid
functionalized particles exhibited extreme behaviors. The same
can be said for the other parameters listed above that were used
in constructing the model. This demonstrates how multiple
material parameters and characteristics inﬂuence cell behavior.
Take, for example, the number of CH2 groups present in the
molecules. The ketal and sulfonic acid modiﬁers have six and
three CH2 groups respectively, whereas the ether modiﬁer has
four CH2 groups but secretes approximately half the TNF-α of
the other two particles. This results from the ether function-
alized particles having a lower Ngroup and fewer oxygen atoms
present in the modiﬁer.
In examining all of the material parameters that inﬂuence
TNF-α expression for LPS and IL-4 stimulated cells, along with
the naiv̈e population, there are several commonalities that
appear. The ﬁrst of which is the number of hydrogen bond
donors and hydrogen bond acceptors, which appear in all three
equations: both LPS stimulated and naiv̈e cells have negative
correlations with the number of hydrogen bond donors while
IL-4 and LPS stimulated macrophages have negative
correlations with the number of hydrogen bond acceptors.
This may be explained by an increase in protein adsorption on
the surface of the particle, which results in an increased
response to the particle.45 In a previous study we measured the
alternative activation of complement through a red blood cell
lysis assay in which the p(NIPAm-co-AAc) particles were
incubated with C4-deﬁcient guinea pig serum. The serum was
separated from the particles, exposed to red blood cells, and the
amount of hemoglobin present in the supernatant was used to
measure the complement activation through the alternative
pathway.34 It is important to note that materials that activate
complement would deplete complement from the serum and
result in a lower measured % lysis. The amount of TNF-α
secreted from LPS and IL-4 stimulated cells negatively
correlated with the % lysis of red blood cells (R = −0.414
and −0.524), meaning that activating complement resulted in
increased TNF-α. The correlation for naiv̈e cells and
complement was −0.167, indicating that there is likely another
explanation for the naiv̈e cells. Another commonality in eqs 1b
and 1c is surface charge. In both of these equations a negatively
charged particle increases the amount of TNF-α. Ngroup in eq 1c
and NK in eq 1a are also reﬂections of the charge or polarity of
the particle. Previous research has shown that TNF-α secretion
is negatively correlated with surface charge.46,47
Although there are similarities in the equations generated for
activated and naiv̈e macrophages, it is important to note that
diﬀerent macrophage states respond diﬀerently to the
modiﬁcations presented in Figure 1. The correlations for
TNF-α secretion for LPS activated with IL-4 activated or naiv̈e
cells are very low (R = −0.084 and −0.133). IL-4 stimulated
cells and naiv̈e macrophages are better correlated (R = 0.689).
The lack of correlation between LPS activated cells and the
other states may be a result of endotoxin tolerance.
4.2. Material Parameters That Inﬂuence Il-10 Secre-
tion in Activated Macrophages. Secretion of IL-10 in the
absence of particles was highest for LPS treated, followed by IL-
4-treated, and naiv̈e cells. LPS priming has been shown to
Figure 4. Plot of experimentally determined (observed) versus predicted values for TNF-α secretion. Error bars represent the standard deviations of
the observed and predicted values. The solid symbols are the training set and the open symbols represent the validation set. (A) LPS-treated cells.
The results for the statistics of the model were the following: Q2Y = 0.931 and R2Y = 0.980. (B) IL-4-treated cells. The results for the statistics of the
model were the following: Q2Y = 0.974 and R2Y = 0.995. (C) Naiv̈e cells. The results for the statistics of the model were the following: Q2Y = 0.843
and R2Y = 0.975.
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induce IL-10 secretion.48−50 Additionally, IL-4-treated macro-
phages are characterized by high IL-10 secretion.51
To determine how material properties inﬂuence IL-10
secretion from LPS- and IL-4-activated macrophages, partial
least-squares analysis was performed on the data set in Figure
3B and the following equations were developed using the
material descriptors in Table 1.
− = − + −
−
IL 10 4.956 0.013 X 0.150 X 0.607H
0.090H
LPS
1 1 v
D
A (2a)
− = − + +
− + +
− N
N N N
IL 10 1.491 0.236H 0.344 X 0.108
0.237 0.487 0.823
IL 4 A
1
H O CH2
(2b)
The results for the goodness of the ﬁts on the training set for
the above equations are as follows: (2a) Q2Y = 0.849, R2Y =
0.948 and (2b) Q2Y = 0.811, R2Y = 0.942 (Figure 5). Because
seven of the particles incubated with naiv̈e cells resulted in IL-
10 secretion below the limit of quantiﬁcation, QSAR was not
performed on the naiv̈e samples. As with the previous cytokine,
a training set (closed symbols) was used to develop the
mathematical model and a validation set (open symbols) was
used to verify the predictive nature of the model.
For M1 macrophages there are negative correlations with
connectivity indices 1 and 2; the number of hydrogen bond
donors; and the number of hydrogen bond acceptors (R =
−0.547, −0.584, −0.957, −0.505). Lysis of red blood cells had a
modest negative correlation with IL-10 (R = −0.355). Because
the correlation between IL-10 secretion and hydrogen bond
donors is quite strong, there may be protein interactions with
the particle other than complement that are contributing to this
strong correlation. In comparing the material parameters for IL-
10 secretion with those for TNF-α for the LPS treated cells, the
negative correlations for both equations with hydrogen bond
donors and acceptors is immediately obvious. The correlation
between these two cytokines is R = 0.517, which further
indicates that they may be released through related interactions
with the particles, which is consistent with previous research
indicating that IL-10 negatively regulates TNF-α.39,49,52
Unlike the LPS treated macrophages, IL-4 macrophages
exhibited positive correlations with all of the parameters used to
develop the mathematical expression in eq 2b (hydrogen bond
acceptors, R = 0.632; connectivity index 1, R = 0.706; the
number of non-hydrogen atoms, R = 0.622; the number of
hydrogen atoms, R = 0.516; the number of oxygen atoms, R =
0.875; and the number of CH2 groups, R = 0.883). The
diﬀerence in dependence on polymer parameters for the two
activations can further be seen in the lack of a correlation
between the IL-10 secreted for LPS- and IL-4-treated cells (R =
0.128).
Similar to the LPS-stimulated cells, the IL-4-treated cells had
a correlation of R = 0.543 between IL-10 and TNF-α secretion.
In comparing the two equations, the correlation between the
two cytokines and the number of CH2 groups is quite strong.
Because hydrogen bonding is present in eqs 1b and 2b, it is
likely that how proteins interact with the particle changes how
the cell responds. Protein adsorption to biomaterials is a very
active ﬁeld of research in biomedical engineering. Increasing the
hydrogen bonding character of a polymer is generally correlated
with excellent blood compatibility,53,54 because of the ability of
the polymer to interact well with water, thus permitting the
protein to retain its tertiary structure.55 eqs 2a and 2b show that
increasing the amount of hydrogen bonding will decrease the
IL-10 secretion for both LPS and IL-4 stimulated cells, thus
indicating that polymers that interact poorly with water will
increase the secretion of IL-10. As with the M1 cells, there was
a low correlation with % lysis (R = −0.337) suggesting that
although a complement may be interacting with the particle,
causing IL-10 to be secreted, there is likely another protein or
protein system that is responsible for altering IL-10 secretion in
IL-4-treated cells.
5. CONCLUSIONS
In summary, we have developed mathematical equations that
have been able to predict TNF-α and IL-10 secretion for LPS-
and IL-4-stimulated cells. TNF-α secretion was also predicted
for naiv̈e cells. All of the equations had a dependence on
hydrogen bond donors and/or hydrogen bond acceptors.
Despite this commonality, there are diﬀerences between the
equations generated that allow for the possibility of
reprogramming cells, or altering the amounts of speciﬁc
cytokines secreted, using polymeric particles without delivery
of a protein. The generalities uncovered in this work pave the
way for altering cellular responses for applications in drug
delivery and tissue engineering.
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